The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.
Helen McShane
The Jenner Institute
University of Oxford
Oxford
UK
Name/email consistency: high
- Vaccine strategies against tuberculosis. McShane, H. Swiss. Med. Wkly (2009)
- Need for more TB vaccine field sites. McShane, H. Indian J. Exp. Biol. (2009)
- Boosting BCG with MVA85A: the first candidate subunit vaccine for tuberculosis in clinical trials. McShane, H., Pathan, A.A., Sander, C.R., Goonetilleke, N.P., Fletcher, H.A., Hill, A.V. Tuberculosis. (Edinb) (2005)
- Co-infection with HIV and TB: double trouble. McShane, H. Int. J. STD. AIDS (2005)
- Prime-boost immunisation strategies for tuberculosis. McShane, H., Hill, A. Microbes Infect. (2005)
- Developing an improved vaccine against tuberculosis. McShane, H. Expert. Rev. Vaccines (2004)
- Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans. McShane, H., Pathan, A.A., Sander, C.R., Keating, S.M., Gilbert, S.C., Huygen, K., Fletcher, H.A., Hill, A.V. Nat. Med. (2004)
- Protective immunity against Mycobacterium tuberculosis induced by dendritic cells pulsed with both CD8(+)- and CD4(+)-T-cell epitopes from antigen 85A. McShane, H., Behboudi, S., Goonetilleke, N., Brookes, R., Hill, A.V. Infect. Immun. (2002)
- Prime-boost immunization strategies for infectious diseases. McShane, H. Curr. Opin. Mol. Ther. (2002)
- Enhanced immunogenicity of CD4(+) t-cell responses and protective efficacy of a DNA-modified vaccinia virus Ankara prime-boost vaccination regimen for murine tuberculosis. McShane, H., Brookes, R., Gilbert, S.C., Hill, A.V. Infect. Immun. (2001)
